title: High rate of human herpesvirus-8 seroprevalence in thalassemic patients in Italy.
abstract: BACKGROUND
  The potential risk of acquiring infection by the novel human herpesvirus-8 (HHV-8) through blood derivatives is still debated.
  
  
  OBJECTIVE
  In the present study, we determined HHV-8 seroprevalence in beta-thalassemic patients living in Italy.
  
  
  METHODS
  We have analysed 86 patients from Sardinia, an island characterised by a high diffusion of HHV-8, as well as 33 thalassemics from the area of Rome, where a lower rate of HHV-8 infection has been reported. These data have been compared with HHV-8 seroprevalence found in healthy controls living in the same areas of the assayed patients.
  
  
  CONCLUSIONS
  A three-fold increase in HHV-8 seroprevalence was found among thalassemic patients when compared to control groups taken from the same regions (17.6% versus 5.1%). This risk factor was statistically significant when considering the Sardinians alone (P = 0.01) and the entire population analysed in the present survey (P = 0.0006). In the Roman area also an increased seroprevalence in thalassemic subjects was found (12.1% versus 4.6%) but it was not statistically significant (P = 0.2). HHV-8 is sporadically present in the blood of healthy individuals and it is unknown whether the virus eventually present in donors' blood is completely cleared by the treatments which blood undergoes before red cells are transfused. Based on these considerations, we hypothesise that multiply transfused subjects living in areas at high HHV-8 prevalence present an increased risk of being infected.
authors.affiliation: Dipartimento di Dermatologia, Università di Sassari, Sassari, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Cottoni
authors.forename: Roberta
authors.initials: R
authors.lastname: Santarelli
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Gentile
authors.forename: Domenico
authors.initials: D
authors.lastname: Gallisai
authors.forename: Angela
authors.initials: A
authors.lastname: Capobianchi
authors.forename: Maria Vittoria
authors.initials: MV
authors.lastname: Masala
authors.forename: Maria Antonietta
authors.initials: MA
authors.lastname: Montesu
authors.forename: Marisa
authors.initials: M
authors.lastname: Coinu
authors.forename: Daniela
authors.initials: D
authors.lastname: Piras
authors.forename: Pietro
authors.initials: P
authors.lastname: Martino
authors.forename: Gabriella
authors.initials: G
authors.lastname: Girelli
authors.forename: Rosanna
authors.initials: R
authors.lastname: Satta
authors.forename: Decio
authors.initials: D
authors.lastname: Cerimele
authors.forename: Luigi
authors.initials: L
authors.lastname: Frati
authors.forename: Alberto
authors.initials: A
authors.lastname: Faggioni
authors.forename: Antonio
authors.initials: A
authors.lastname: Angeloni
mesh_terms: D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D000956:Antigens, Viral / Q000276:immunology; D005260:Female; D006566:Herpesviridae Infections / Q000453:epidemiology* / Q000276:immunology; D019288:Herpesvirus 8, Human / Q000276:immunology*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D013789:Thalassemia / Q000150:complications*; D065227:Transfusion Reaction
chemical_list: D000914:Antibodies, Viral; D000956:Antigens, Viral